Nuclear Imaging

PET/CT, recurrent prostate cancer, fluciclovine F-18, Emory University

CTVPOST (red) = CTVPRE (yellow) union CTVPET (pink). Also shown (upper right corner) are the PRE (square) vs POST (triangle) dose volume histograms for PTV1, PTV2, rectum, bladder, and penile bulb, showing minimal impact on target coverage or organs at risk dose with the modified targets. Image courtesy of Ashesh B. Jani, M.D., and David Schuster, M.D., Emory University.

News | Radiopharmaceuticals and Tracers | March 16, 2017

The featured clinical investigation article of the March 2017 issue of the Journal of Nuclear Medicine demonstrates...

FDG PET/CT, lung cancer, radiation therapy, AJR study, American Journal of Roentgenology
News | Lung Cancer | March 13, 2017

FDG positron emission tomography/computed tomography (PET/CT) is a valuable imaging tool for treatment assessment of...

Nuclear cardiology, nuclear imaging, radiotracer production, automated radiosynthesis module, myocardial perfusion imaging
Feature | Radiopharmaceuticals and Tracers | March 10, 2017 | Anamika Kumari

Huge portions of the globally produced radiotracers find their origin within geographically centralized, commercial...

X0000_Piramal_Neuraceq PET agent_beta amyloid plaque imaging.jpg
News | Radiopharmaceuticals and Tracers | March 09, 2017

March 9, 2017 — Piramal Imaging SA and Isologic Innovative Radiopharmaceuticals recently announced that Health...

Navidea, Lymphoseek, North American rights, sale, Cardinal Health
News | Radiopharmaceuticals and Tracers | March 08, 2017

Navidea Biopharmaceuticals announced the completion of the sale of its Lymphoseek product to Cardinal Health....

PET imaging, atherosclerotic plaque, inflammation, Ga-68-pentixafor, Technishe Universitat Munchen, Germany

Note the high uptake of Ga-68-pentixafor on multi-planar reconstructions in the organs expressing CXCR4 such as the spleen (red arrows) and adrenal glands (yellow arrows), which was nearly completely blocked by the pre-injection of AMD 3100, a potent CXCR4 inhibitor. Strong accumulation of Ga-68-pentixafor was also found in the kidneys (asterisks) reflecting the renal clearance of the tracer. In addition, high, focal activities were detected in the abdominal aorta (red arrowheads) and right carotid artery (orange arrowheads) of atherosclerotic rabbits, whereas no significant signal could be detected in the non-injured left carotid artery (white arrowheads) of atherosclerotic and control rabbits, as well as in the abdominal aorta and right carotid artery of control rabbits. Furthermore, focal activities detected with PET in atherosclerotic plaques of the abdominal aorta and the right carotid artery decreased significantly when the same rabbit was re-imaged after blocking CXCR4 receptors. Image courtesy of Fabien Hyafil, M.D., Ph.D., Department of Nuclear Medicine, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany

News | PET Imaging | March 03, 2017

March 3, 2017 — In the featured article of the March 2017 issue of...

Figure 1: Digital/synthetic reference object (DRO) analysis of the medical imaging market.

Feature | Imaging | March 02, 2017 | By Infinium Global Research

The emerging markets of Asia-Pacific and Latin America will drive the medical imaging market by more than 5 percent...

brain SPECT imaging, dementia, depression, Daniel G. Amen

Representative brain SPECT scans in a patient with Alzheimer's dementia showing substantially reduced brain blood flow in the temporal and parietal lobes compared to a person with depression with mild decreased frontal lobe blood flow. Image courtesy of Amen Clinics.

News | SPECT Imaging | February 22, 2017

February 22, 2017 — Does a patient have depression or a cognitive disorder (CD) such as Alzheimer's disease or both...

News | Radiopharmaceuticals and Tracers | February 16, 2017

Cerveau Technologies Inc. announced it has signed an agreement with Siemens’ PETNET Solutions Inc. that grants the...

Blue Earth Diagnostics, Axumin, fluciclovine F-18, recurrent prostate cancer, Simens PETNET Solutions, increased patient access
News | Radiopharmaceuticals and Tracers | February 07, 2017

Blue Earth Diagnostics and Siemens’ PETNET Solutions announced that an increasing number of radiopharmacies will...

radiotargeted therapy, SST2 antagonists, combat cancer, neuroendocrine tumors, NETs, Journal of Nuclear Medicine study

Comparative receptor autoradiography in various cancer types (A = HE staining) with I-125-JR11 (B+C) and I-125-Tyr3-octreotide (D+E). B and D are the respective total binding, C and E the respective non-specific binding. Bars = 1 mm.

I: Breast cancer. II: Renal cell cancer. III: Medullary thyroid cancer. IV: Non-Hodgkin lymphoma. V: Colon cancer. In cancers I-V, the sections were incubated with 30’000 cpm/100 μl of antagonist or agonist. Cancers I-IV show a much higher density of sst2 with the antagonist. The colon cancer V is negative. VI: Ileal NET, incubated with 10’000 cpm/100 μl of antagonist or agonist. Credit: Jean Claude Reubi, Institute of Pathology, University of Berne, Berne, Switzerland. 

News | Radiation Therapy | February 06, 2017

A study published in the February issue of The Journal of Nuclear Medicine demonstrates the potential of extending...

PET/CT, primary and metastatic prostate cancer, Journal of Nuclear Medicine study, JNM

Ga-68-BBN PET/CT of a 64-year-old man newly diagnosed with prostate cancer by biopsy. Multiple bone metastasis lesions (arrows) were detected. Image courtesy of Jingjing Zhang, Peking Union Medical College, Beijing, China.

News | Prostate Cancer | February 02, 2017

In the featured article from the February 2017 issue of the Journal of Nuclear Medicine, researchers document the...

IBA Molecular, acquisition, Mallinckrodt Nuclear Imaging, nuclear imaging
News | Nuclear Imaging | January 30, 2017

IBA Molecular has successfully completed its acquisition of Mallinckrodt Nuclear Imaging, announced in August 2016,...

Gamma Medica, LumaGEM molecular breast imaging system, MBI technology, Major Health Partners Indiana
News | Breast Imaging | January 26, 2017

Gamma Medica recently announced that through its collaboration with Ohio-based Alpha Imaging, Indiana-based Major...

News | PET Imaging | January 25, 2017

In work published this week in the Journal of Clinical Investigation (JCI), a team led by Jacob Hooker at Harvard...

stress, brain activity, cardiovascular risk, PET-CT, MGH, ISSMS, The Lancet study
News | Neuro Imaging | January 18, 2017

A study led by Massachusetts General Hospital (MGH) and Icahn School of Medicine at Mount Sinai (ISSMS)...

News | Radiopharmaceuticals and Tracers | January 17, 2017

NorthStar Medical Technologies LLC has received additional matching funds from the U.S. Department of Energy’s ...

Medrad Intego PET Infusion System, recall
News | Nuclear Imaging | January 12, 2017

January 12, 2017 — Bayer Healthcare has initiated a recall of all its Medrad Intego PET Infusion System Source...

Mirada Medical, RSNA 2016, XD:PACS, molecular imaging, nuclear imaging
Technology | PACS | January 06, 2017

Mirada Medical showcased its latest XD:PACS (picture archiving and communication system) range of molecular imaging...

SPECT-CT, 3-D printing, University of Wurzburg, Germany, Johannes Tran-Gia, dosimetry calibration

SPECT/CT reconstructions and VOIs used for determination of calibration factors for the adult kidney filled with Lu-177 (A) and the corresponding sphere filled with I-131 (B). Credit: University of Würzburg

News | 3-D Printing | January 06, 2017

In nuclear medicine, the goal is to keep radiation exposure at a minimum, while obtaining quality images. Optimal...

Overlay Init